Indl. Inv. Trust

IITL04 Mar 2024
Finance
+1.15 (+0.55%)
Lowest Today
Highest Today
Today’s Open
Prev. Close
52 Week High
52 Week Low
To Invest in Indl. Inv. Trust
Indl. Inv. Trust
Finance
IITL04 Mar 2024
+1.15 (+0.55%)
OverviewFundamentals
1D
1M
6M
1Y
5Y
All

Indl. Inv. Trust - Share Price & Details

Lowest Today
208.9
Highest Today
219
Today’s Open
210
Prev. Close
209.75
52 Week High
284.95
52 Week Low
68.05
Traded Volume
Market Cap(Cr)
Avg Traded Price
1 Year return
120.66%
Upper Circuit
Lower Circuit
P/E TTM
23.92
P/B Ratio
1.32
Traded Value(Cr)
0.00
EPS TTM
8.77
Book value
Dividend
0.00%

Price Performance

-13.84 %
1 Wk
-19.65 %
1 M
18.12 %
3 M
120.66 %
1 Y
9.55 %
YTD

Traded Volume Movement

Technical Details

Support 3
202
Support 2
205
Support 1
209
Pivot Point :
212
Resistance 1
216
Resistance 2
219
Resistance 3
223

Peer Comparison

Scrip NamePriceDaily ChangeM.Cap (Cr)1 Year Returns %P/E (TTM)PB Ratio
Industrial Investment Trust Ltd
₹210.90(+1.15/0.55%)
210.90+1.15472.93120.6623.921.32
Tata Investment Corporation Ltd
₹8,417.65(+400.80/5.00%)
8,417.65+400.8040,561.49276.08144.941.72
Alfred Herbert (India) Ltd
₹1,705.25(-89.75/-5.00%)
1,705.25-89.75138.22149.39143.141.37
Maharashtra Scooters Ltd
₹7,558.25(+37.25/0.50%)
7,558.25+37.258,596.5068.5942.980.35
Utique Enterprises Ltd
₹8.39(+0.01/0.12%)
8.39+0.0146.6564.5769.830.66
Bajaj Holdings & Investment Ltd
₹8,943.65(-100.70/-1.11%)
8,943.65-100.70100,654.5741.8957.946.00

About Industrial Investment Trust Ltd

Industrial Investment Trust Ltd is in the Finance sector, having a market capitalization of Rs. 472.93 crores. It has reported a sales of Rs. 7.86 crores and a net profit of Rs. 19.57 crores for the quarter ended December 2018. The company management includes B Samal, B Samal,Bipin Agarwal,Venkatesan Narayanan,Sujata Chattopadhyay,Milind Sitaram Desai (Industrial Investment Trust Ltd) among others.
Chairman
B Samal
Registered office
14E Rajabahadur Mansion 2nd Fl,28 Bombay Samachar Marg Fort,Mumbai,Maharashtra,400001
FAX :91-22-22651105
Background
Incorporation Year1933
Face Value₹10
Market Lot1

Latest News

Large caps likely to outperform broader market: Analysts
The Indian market is poised to maintain its positive momentum, with large-cap stocks expected to outperform the broader market. This trend is indicated by the Nifty vs Nifty 500 ratio reaching its lowest point. Analysts anticipate Nifty to climb towards 22,800, provided it remains above 22,300. Some of the recommended stocks include Reliance Industries, Axis Bank, ICICI Bank, SBI, Infosys.
04 Mar 2024 | 10:05 AM
Chartist Talks | What makes Rohit Srivastava of India charts bullish?
After the Nifty 50 hit a new record high last week, the trendline indicated a new resistance near 22,360. The index needs to trade above this level for a few days to prove that the breakout from consolidation was sustainable, according to Rohit Srivastava, founder of Strike Money Analytics and India charts. The veteran with nearly three decades spent in the equity markets.
04 Mar 2024 | 09:53 AM
Stocks To Watch: ZEE, JIO Financials, Paytm, Axis Bank, Asian Paints!
GIFT Nifty indicated that Indian equity indices BSE Sensex and NSE Nifty 50 may see a positive opening on Monday. Here’s a look at the key stocks to watch in trade. Stocks in Focus: GIFT Nifty traded up by 60.50 points or 0.27% at 22,511 indicating a positive opening for domestic indices NSE Nifty 50 and BSE Sensex on Monday.
04 Mar 2024 | 09:32 AM
📢 Benchmark indices open on a flat note today; Nifty near 22,402.
📈 Amid mixed global cues, benchmark indices started on a flat note today. 📊 At 9:16 AM, the Sensex gained 96.94 points or 0.13% at 73,903.09 and the Nifty was up 25.10 points or 0.11% at 22,401.50. 📢NTPC (⬆️2.19%), and Nifty Energy (⬆️0.67%) appeared as the top performers on the Nifty50 at open. Tata Steel and JSW Steel are in focus today.
04 Mar 2024 | 09:21 AM
These pharma and healthcare microcap multibaggers turned MF favourites!
After putting up a tepid performance in 2022, pharma and healthcare funds made a strong comeback over the last 15 months with the Nifty Pharma index significantly outperforming the Nifty 50. Experts attribute this to a stable pricing environment in the US. So far this year, the pharmaceutical funds category yielded 10 percent returns, while the Nifty 50 index gained only 1 percent.
04 Mar 2024 | 09:14 AM
Click here to see your activities